Atrium Therapeutics, Inc. financial statements
Atrium Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 18.62M | EODHD |
| Net income | −USD 76.68M | EODHD |
| Cash and equivalents | USD 270M | EODHD |
| Total debt | USD 3.67M | EODHD |
Atrium Therapeutics, Inc. financials on 6ix · Atrium Therapeutics, Inc. on 6ix